COVID-19 Oral Prescription Treatment Campaign
58% lift
in likelihood to get a COVID-19 vaccine
42% lift
in likelihood to discuss COVID-19 oral Rx options
Objective
Increase awareness and usage of COVID-19 oral prescription (Rx) treatment among Walmart pharmacy shoppers and influence shoppers to talk to their health care provider about COVID-19 oral Rx treatments.
Solutions
To drive awareness and usage of COVID-19 oral prescription treatments available at Walmart on Perion’s Walmart Pharmacy POC Healthcenters.
Research Approach
A third-party, independent, research partner, MFour Mobile Research, collected a total of 400 mobile interviews during the campaign from October 17 to December 31, 2024 among Walmart Pharmacy shoppers. On average, it took Walmart Pharmacy shoppers 10 minutes to complete the mobile survey. Pharmacy shoppers who successfully completed the survey were incentivized by MFour Mobile Research.
Results
Based on Walmart pharmacy shopper mobile survey data, the campaign delivered a significant increase in likelihood to talk to a Walmart pharmacist about COVID Rx oral treatment options and to get a COVID-19 vaccine at a Walmart pharmacy. When comparing mobile survey responses, collected during the campaign, between the exposed vs. control (baseline) Walmart Pharmacy shoppers, there was a:
- 58% significant lift in likelihood to get a COVID-19 vaccine at a Walmart pharmacy
- 42% significant lift in likelihood to talk to a Walmart pharmacist about COVID-19 oral Rx treatment options
Ready to turn retail media into measurable results? Talk to our Perion team.
Source:COVID-19 prescription oral treatment study, December 2024, MFour Mobile Research. Member data is based on mobile survey self reported data, 95% significance.
